Analysts expect that Cerner Co. (NASDAQ:CERN) will announce sales of $1.44 billion for the current fiscal quarter, Zacks Investment Research reports. Eleven analysts have made estimates for Cerner’s earnings. The lowest sales estimate is $1.42 billion and the highest is $1.45 billion. Cerner reported sales of $1.37 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 5.1%. The firm is expected to report its next quarterly earnings results on Thursday, August 1st.

According to Zacks, analysts expect that Cerner will report full year sales of $5.74 billion for the current year, with estimates ranging from $5.66 billion to $5.79 billion. For the next fiscal year, analysts forecast that the firm will report sales of $6.11 billion, with estimates ranging from $5.92 billion to $6.25 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Cerner.

Cerner (NASDAQ:CERN) last released its earnings results on Thursday, April 25th. The company reported $0.61 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.55 by $0.06. The firm had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Cerner had a net margin of 11.65% and a return on equity of 14.86%. Cerner’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.58 EPS.

Several analysts have commented on the stock. Zacks Investment Research cut shares of Cerner from a “hold” rating to a “sell” rating in a research note on Thursday, February 21st. BidaskClub raised shares of Cerner from a “hold” rating to a “buy” rating in a research note on Thursday, May 9th. Barclays reaffirmed a “hold” rating and issued a $68.00 target price on shares of Cerner in a research note on Wednesday, April 10th. Citigroup set a $77.00 price objective on shares of Cerner and gave the company a “buy” rating in a research note on Wednesday, April 10th. Finally, Morgan Stanley cut shares of Cerner from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $68.00 to $47.00 in a research note on Thursday, February 28th. One analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $68.67.

CERN stock opened at $68.48 on Monday. The company has a market capitalization of $22.28 billion, a price-to-earnings ratio of 30.99, a PEG ratio of 2.10 and a beta of 1.03. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.58 and a quick ratio of 2.55. Cerner has a one year low of $48.78 and a one year high of $69.65.

In related news, Director John J. Greisch acquired 9,000 shares of the stock in a transaction dated Thursday, May 2nd. The stock was bought at an average cost of $67.57 per share, with a total value of $608,130.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director R Halsey Wise acquired 7,600 shares of the stock in a transaction dated Tuesday, April 30th. The shares were bought at an average cost of $65.76 per share, with a total value of $499,776.00. The disclosure for this purchase can be found here. 4.71% of the stock is owned by insiders.

Several large investors have recently bought and sold shares of the stock. Adell Harriman & Carpenter Inc. lifted its holdings in shares of Cerner by 0.6% during the 4th quarter. Adell Harriman & Carpenter Inc. now owns 31,427 shares of the company’s stock valued at $1,648,000 after acquiring an additional 200 shares in the last quarter. Moody National Bank Trust Division lifted its holdings in shares of Cerner by 72.5% during the 1st quarter. Moody National Bank Trust Division now owns 483 shares of the company’s stock valued at $28,000 after acquiring an additional 203 shares in the last quarter. Advisor Partners LLC lifted its holdings in shares of Cerner by 3.0% during the 1st quarter. Advisor Partners LLC now owns 6,907 shares of the company’s stock valued at $395,000 after acquiring an additional 203 shares in the last quarter. ETF Managers Group LLC lifted its holdings in shares of Cerner by 9.7% during the 1st quarter. ETF Managers Group LLC now owns 2,466 shares of the company’s stock valued at $141,000 after acquiring an additional 218 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its holdings in shares of Cerner by 0.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 50,176 shares of the company’s stock valued at $2,871,000 after acquiring an additional 241 shares in the last quarter. Institutional investors and hedge funds own 80.16% of the company’s stock.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: How to trade on quiet period expirations

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.